Medical News

• share
• favorite_border

Young adults who drink heavily reported that a specific intervention that provides personalized feedback on daily drinking would be beneficial for people who want to reduce their drinking and would encourage self-reflection among those who are not yet ready to change their drinking habits. The young adults were participants in a pilot study of a first-of-its-kind technology aimed at reducing heavy drinking in young adults through self-selected goal setting and daily personalized feedback based on self-reported behaviors related to drinking. The study is described in Alcohol: Clinical and Experimental Research.

• share
• favorite_border

A research team has uncovered alarming levels of air and water pollution near cement and oil factories in Delta, Nigeria.

• share
• favorite_border

A research team highlights the critical role of dedicated exits in improving emergency evacuation efficiency for vulnerable populations, such as the elderly and disabled.

• share
• favorite_border

People with alcohol use disorder (AUD) who are at risk of advanced liver disease are less likely to be referred for liver evaluation and care if they present primarily with alcohol-related mental health issues or a mental health diagnosis, according to a study of referral practices in Virginia’s largest health system. The findings point to the possibility of widespread missed opportunities for treating three conditions that commonly co-occur: AUD, mental health disorders, and liver disease. Recent years have seen notable increases in the USA in alcohol-related deaths, mental health disorders, and hospital admissions relating to alcohol use and concurrent mental health conditions. AUD is a significant cause of liver disease, and both addiction and co-occurring mental illness can be barriers to successful liver treatment. Integrating AUD treatment, mental health care, and hepatology (liver care) is necessary to improve outcomes, but data suggests this approach is not the norm. For the st

• share
• favorite_border

• share
• favorite_border

Dr. Bruce Greyson is a distinguished professor emeritus of psychiatry and behavioral sciences at the University of Virginia. With an academic journey spanning over half a century, Dr. Greyson has dedicated a significant portion of his career to the study of near-death experiences (NDEs).

• share
• favorite_border

Florida State University’s College of Nursing has launched the nation’s first master’s degree combining artificial intelligence and health care with a curriculum that will expand digital health initiatives into clinical benefits for patients through more advanced, efficient and personalized care.

• share
• favorite_border

A mother and daughter survive complex brain aneurysms, including the daughter's ruptured aneurysm, after receiving care from neurosurgeon Rafael De Oliveira Sillero, M.D., and his partners at UT Southwestern Medical Center.

• share
• favorite_border

Friday, September 20, 2024, CLEVELAND: A Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery was associated with a significant decrease in the progression of chronic kidney disease compared to those who received GLP-1 diabetes medications. The paper was published in Annals of Surgery.

• share
• favorite_border

Denise Côté-Arsenault, Ph.D., an internationally recognized expert in pregnancy loss at Saint Louis University’s Trudy Busch Valentine School of Nursing, will work with a group of Ph.D. midwives on their research on parent experiences with pregnancy and birth with life-limiting fetal diagnosis.

• share
• favorite_border

Today, the FDA announced the first approved treatment for Niemann-Pick Type C (NPC) disease: an oral medication named Miplyffa (arimoclomol). Sean Kassen, director of the Ara Parseghian Medical Research Fund at the University of Notre Dame, said this represents the beginning of a new and hopeful era for NPC families.

• share
• favorite_border

$5 million gift from The Bob & Renee Parsons Foundation expands capacity for therapy, research, and training on psychedelic-assisted therapy

• share
• favorite_border

lec Pollard, Ph.D., professor emeritus of family and community medicine, recently received the International OCD Foundation (IOCDF)’s 2024 Outstanding Career Achievement Award. The IOCDF Awards recognize exceptional individuals and professionals for their dedicated efforts in advancing awareness, advocacy, and understanding of obsessive-compulsive disorder.

• share
• favorite_border

Dr. Jeremie Calais received two grants from Novartis totaling $4 million aimed at improving the effectiveness of the radiation-emitting targeted therapy 177-Lu-PSMA-617 for patients with metastatic castration-resistant prostate cancer (mCRPC), one of the most challenging forms of the disease.

• share
• favorite_border

• share
• favorite_border

An eight-year project aims to uncover the complex web of interacting factors that drive oral health inequity, which in turn affects many other serious health conditions.

• share
• favorite_border

Cedars-Sinai has announced a partnership with the LA28 Olympic and Paralympic Games to serve as the Official Medical Provider for the 2028 Games, providing the highest-quality care for athletes, coaches, team personnel and visitors who travel across the world for the competitions in Los Angeles.

• share
• favorite_border

Cedars-Sinai ha anunciado hoy su asociación con los Juegos Olímpicos y Paralímpicos de LA28 para fungir como proveedor médico oficial de los Juegos de 2028, proporcionando atención de la más alta calidad a los atletas, entrenadores, personal del equipo y visitantes que viajen de todo el mundo con motivo de las competencias en Los Ángeles.